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Summary
During 1986–1997, the number of tuberculosis (TB) cases among foreign-
born persons in the United States increased by 56%, from 4,925 cases (22% of
the national total) to 7,702 cases (39% of the national total). As the percentage of
reported TB cases among foreign-born persons continues to increase, the elimi-
nation of TB in the United States will depend increasingly on the elimination of
TB among foreign-born persons.
On May 16–17, 1997, CDC convened a working group of state and city TB-
control program staff, as well as representatives from CDC’s Division of TB
Elimination and Division of Quarantine, to outline problems and propose solu-
tions for addressing TB among foreign-born persons. The Working Group on
Tuberculosis Among Foreign-Born Persons considered a) epidemiologic profiles
of TB cases among foreign-born persons, b) case finding, screening, and pre-
ventive therapy for the foreign born, c) TB diagnosis and management for the
foreign born, d) opportunities for collaborations with community-based organi-
zations (CBOs) to address TB among the foreign born, and e) TB-related training
needs.
The Working Group’s deliberations and the resulting recommendations for
action by federal agencies, state and local TB-control programs, CBOs, and pri-
vate health-care providers form the basis of this report. For each of the five
topics of discussion, the group identified key issues, problems, and constraints
and suggested solutions in the form of recommendations, which are detailed in
this report. The Working Group made the following recommendations:
• The epidemiology of TB among foreign-born populations differs considerably
from area to area. To tailor TB-control efforts to local needs, TB-control pro-
grams should develop epidemiologic profiles to identify groups of
foreign-born persons in their jurisdictions who are at high risk for TB.
• The priorities of TB control among the foreign born should be the same as
those for control of TB among other U.S. populations — completion of treat-
ment by persons infected with active TB, contact tracing, and screening and
provision of preventive therapy for groups at high risk. Screening and preven-
tive therapy should be limited to areas where completion of therapy rates and
contact-tracing activities are currently adequate.
• Based on local epidemiologic profiles, selective screening should be con-
ducted among populations identified as being at high risk for TB. Screening
should target groups of persons who are at the highest risk for TB infection
and disease, accessible for screening, and likely to complete preventive ther-
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apy. The decision to screen for infection, disease, or both should be based on
the person’s age and time in the United States, prior screening, and locally
available resources for the provision of preventive therapy.
• TB-control programs should direct efforts towards identifying impediments to
TB diagnosis and care among local foreign-born populations, devising strate-
gies to address these barriers, and maximizing activities to ensure completion
of treatment.
• Providing TB preventive therapy and other TB-related services for foreign-
born persons is often impeded by linguistic, cultural, and health-services
barriers. TB-control programs can help overcome these barriers by estab-
lishing partnerships with CBOs and by strengthening training and education
efforts. Collaborations with health-service CBOs should center on developing
more complementary roles, more effective coordination of services, and bet-
ter use of existing resources for serving the foreign born. TB-related training
should be linked to overall TB-control strategies for the foreign born. Training
and education should be targeted to providers, patients, and community
workers.
INTRODUCTION
In 1986, CDC began collecting information on place of birth for those persons resid-
ing in the United States who have been reported to be infected with tuberculosis (TB).
National surveillance data for the decade that followed indicate that the number of TB
cases among persons born in other countries increased from 4,925 in 1986 to 7,702 in
1997, and that the percentage of foreign-born cases increased from 22% to 39% of the
national total. In Canada and several European countries, foreign-born persons now
account for more than half of TB cases. If current U.S. trends continue through the
next decade, more than half of TB cases are likely to occur among the foreign born.
BACKGROUND
Immigration Trends
The increase in TB cases among foreign-born persons over the past decade is
partly attributable to increased immigration (Figure 1). The largest wave of immigra-
tion in U.S. history occurred in the early 1900s; by 1910, 14% of all U.S. residents were
foreign born. Immigration declined during the next two decades, reached a low during
the Great Depression (1929–1939), and then gradually increased until the mid-1980s.
A peak occurred in 1986, when the Immigration Reform and Control Act was passed
and persons who had entered the country illegally were allowed to legalize their
status. In 1996, the most recent year for which immigration figures are available,
915,900 persons were granted permanent residence (1 ). In addition, an estimated
275,000 undocumented aliens arrive annually. In 1996, an estimated 24.6 million
foreign-born persons resided in the United States, representing 9% of the total popu-
lation (2 ).
2 MMWR September 18, 1998
Another factor in the increase in TB cases among foreign-born persons is changing
trends in countries of origin. Immigration has been increasing from Asia and the Latin
Americas, where TB rates are 5–20 times higher than those in the United States. In
1994, 25% of the 24 million foreign-born persons in the United States were from Asia
and 42% from Latin America, including 6 million persons from Mexico (2 ). In recent
years, Asian-born persons have accounted for an increasing percentage of new immi-
grants; in 1995, 37% of new arrivals were from Asia (3 ). After Mexico, the top two
countries of birth among immigrants in that year were the Philippines and Vietnam.
The foreign-born population is concentrated in some areas in the United States.
Forty-three percent of such persons live in California (34%) or New York (9%). Florida,
Texas, New Jersey, and Illinois each have 5%–8% of the total foreign-born population
(2 ). In 1995, two thirds of immigrants indicated California, New York, Florida, Texas,
New Jersey, and Illinois as their intended residence at the time of immigration, and
approximately one fourth of all new immigrants indicated an intent to live in Los An-
geles or New York City (3 ).
Characteristics of TB Cases Among Foreign-Born Persons
The composition of TB cases among foreign-born persons reflects immigration
patterns and trends. In 1997, Mexico was the country of origin for 22% of immigrants
with TB, with the Philippines (14%) and Vietnam (11%) the next most common coun-
tries of birth. India, China, Haiti, and Korea each accounted for 3%–6% of the total.
0
150,000
300,000
450,000
600,000
750,000
900,000
1,050,000
1,200,000
1,350,000
1,500,000
1,650,000
1,800,000
1,950,000
1900 1910 1920 1930 1940 1950 1960 1970 1980 1994
Fiscal Year
N
u
m
be
r 
of
 Im
m
ig
ra
nt
s
Source: U.S. Department of Justice, Immigration and Naturalization Service. Statistical yearbook
of the Immigration and Naturalization Service, 1996. Washington D.C.: U.S. Government Printing
Office, 1997.
FIGURE 1. Immigrants admitted to the United States during fiscal years 1900–1994
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Together, these seven countries accounted for two thirds of TB cases among foreign-
born persons in the United States.
As expected, most TB cases among foreign-born persons are reported from the
states with the most immigrants. In 1997, 66% of all TB cases among foreign-born
persons were reported from California (36% of the national total), New York (15%),
Texas (8%), Florida (5%), New Jersey (4%), Illinois (3%), Washington (2%), Massachu-
setts (2%), Virginia (2%), and Hawaii (2%) (Table 1). In 1997, TB cases among
foreign-born persons were examined as a proportion of total TB cases in each state. A
total of 66% of TB cases occurred among foreign-born persons in California and 51%
in New York. Even in states with relatively few cases among the foreign born (e.g.,
Minnesota and Rhode Island), approximately 60% of TB cases in 1997 were among
persons born outside the United States.
Most TB cases among foreign-born persons are likely the result of reactivation of
remotely acquired infection, although some transmission is probably occurring in the
United States. Studies using the restriction-fragment-length polymorphism (RFLP)
technique document transmission to the foreign born by others who are foreign born
or U.S. born (4 ); other studies document high percentages of cases among the chil-
dren of the foreign born (5 ). For all immigrant groups, the disease risk appears
highest in the first years after U.S. arrival (Figure 2). Among some groups, the risk
decreases rapidly over time, whereas for others, it remains high for up to 20 years (6) .
The risk for disease among the foreign born also appears related to chronological age
and age at immigration; younger persons and those who immigrated at younger ages
are at lower risk for subsequent infection with TB.
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FIGURE 2. Rates of reported tuberculosis by place of birth, age, and length of residence
in the United States, 1986–1994
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TABLE 1. Tuberculosis cases among U.S.- and foreign-born persons — United States, 1997
State
Total
cases
U.S.-born persons
Foreign-born
persons* Unknown
No. % No. % No. %
United States 19,851 11,898 59.9 7,702 38.8 251 1.3
Alabama 405 384 94.8 21 5.2 0 0
Alaska 78 60 76.9 18 23.1 0 0
Arizona 296 185 62.5 109 36.8 2 0.7
Arkansas 200 182 91.0 16 8.0 2 1.0
California 4,056 1,243 30.6 2,795 68.9 18 0.4
Colorado 94 43 45.7 48 51.1 3 3.2
Connecticut 128 74 57.8 54 42.2 0 0
Delaware 39 26 66.7 13 33.3 0 0
District of Columbia 110 86 78.2 17 15.5 7 6.4
Florida 1,400 988 70.6 408 29.1 4 0.3
Georgia 696 570 81.9 115 16.5 11 1.6
Hawaii 167 41 24.6 126 75.4 0 0
Idaho 15 6 40.0 9 60.0 0 0
Illinois 974 727 74.6 223 22.9 24 2.5
Indiana 168 143 85.1 24 14.3 1 0.6
Iowa 74 37 50.0 34 45.9 3 4.1
Kansas 78 42 53.8 23 29.5 13 16.7
Kentucky 198 184 92.9 14 7.1 0 0
Louisiana 406 380 93.6 23 5.7 3 0.7
Maine 21 16 76.2 5 23.8 0 0
Maryland 340 208 61.2 132 38.8 0 0
Massachusetts 268 83 31.0 185 69.0 0 0
Michigan 374 320 85.6 54 14.4 0 0
Minnesota 161 46 28.6 114 70.8 1 0.6
Mississippi 245 235 95.9 10 4.1 0 0
Missouri 248 197 79.4 51 20.6 0 0
Montana 18 15 83.3 3 16.7 0 0
Nebraska 22 11 50.0 11 50.0 0 0
Nevada 112 56 50.0 56 50.0 0 0
New Hampshire 17 8 47.1 9 52.9 0 0
New Jersey 718 379 52.8 339 47.2 0 0
New Mexico 71 51 71.8 20 28.2 0 0
New York 2,265 1,119 49.4 1,146 50.6 0 0
North Carolina 463 393 84.9 70 15.1 0 0
North Dakota 12 7 58.3 5 41.7 0 0
Ohio 286 226 79.0 59 20.6 1 0.3
Oklahoma 212 169 79.7 28 13.2 15 7.1
Oregon 161 94 58.4 67 41.6 0 0
Pennsylvania 528 399 75.6 123 23.3 6 1.1
Rhode Island 38 13 34.2 23 60.5 2 5.3
South Carolina 328 308 93.9 20 6.1 0 0
South Dakota 19 18 94.7 1 5.3 0 0
Tennessee 467 423 90.6 43 9.2 1 0.2
Texas 1,992 1,234 61.9 626 31.4 132 6.6
Utah 36 16 44.4 20 55.6 0 0
Vermont 6 4 66.7 2 33.3 0 0
Virginia 350 205 58.6 143 40.9 2 0.6
Washington 305 114 37.4 191 62.6 0 0
West Virginia 54 51 94.4 3 5.6 0 0
Wisconsin 130 78 60.0 52 40.0 0 0
Wyoming 2 1 50.0 1 50.0 0 0
Source: CDC. Reported tuberculosis in the United States, 1997. Atlanta, GA: US Department of
Health and Human Services, CDC National Center for HIV, STD, and TB Prevention, July 1998.
*Persons born outside the United States, American Samoa, Federated States of Micronesia,
Guam, Marshall Islands, Midway Island, Northern Mariana Islands, Puerto Rico, Republic of
Palau, U.S. Minor Outlying Islands, U.S. Miscellaneous Pacific Islands, and U.S. Virgin Islands.
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The number of foreign-born persons in the United States with TB infection is un-
known. However, based on the World Health Organization (WHO) estimate that one
third of the world’s population is infected, more than 7 million foreign-born persons in
the United States might be at risk for reactivation of remotely acquired infection.
PRIORITIES FOR ELIMINATING TB IN THE UNITED STATES
As the percentage of reported TB cases among foreign-born persons continues to
grow, the elimination of TB in the United States will depend increasingly on the elimi-
nation of TB among the foreign born. Although this factor presents challenges and
requires a flexible approach, the priorities of TB control remain the same — a) finding
persons with active disease and ensuring completion of treatment; b) tracing the con-
tacts of those with active disease and evaluating each contact’s status regarding TB
infection and disease; and c) screening persons at high risk for infection, providing
preventive therapy to eligible candidates, and ensuring completion of that preventive
therapy (7 ).
TB Case Finding, Screening, and Preventive Therapy
In the United States, TB screening is required for a) immigrants and refugees apply-
ing for permanent legal status and b) persons of foreign birth (e.g., business persons,
students, and dependents) who entered the country on nonimmigrant visas and want
to adjust their immigration status to legal permanent resident. Each year, active case
finding is conducted on approximately 800,000 persons applying for long-term resi-
dence. In recent years, approximately half have been screened overseas and half in
the United States.
Immigrants and refugees who want to enter the United States are screened over-
seas by local physicians designated by U.S. consuls. Persons with suspected TB
disease are assigned a specific classification — Class A, B1, B2, or B3. The screening
procedure consists of initial radiologic screening for persons aged >15 years followed
by sputum smear microscopy for acid-fast bacilli (AFB) in those whose radiographs
are compatible with active TB. Persons who are AFB-smear–positive (designated
Class A) must be treated before departure. Those who are smear-negative, but whose
radiographs are compatible with active TB (Class B1) or with inactive disease (Class
B2), are referred to a health department in the state of their intended residence for
further evaluation. (Those persons with abnormal radiographs indicating calcified
granulomas not indicative of active TB are Class B3 and are not referred for additional
evaluation.) U.S. screening practices differ from those of other industrialized coun-
tries, which require negative cultures.
The yield of the overseas screening process has been well documented; 3%–14% of
the approximately 6,000 Class B1 immigrants and 0.4%–4% of the 12,000 Class B2
immigrants who enter the country each year are infected with active TB after arrival in
the United States (8 ). Of those without evidence of active TB, many have positive
tuberculin skin tests and radiologic abnormalities compatible with old TB; these per-
sons are at high risk for reactivation and are candidates for preventive therapy
regardless of age. A study in Seattle determined that approximately half of Class B1
immigrants and one fourth of Class B2 immigrants were considered candidates for
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preventive therapy (9 ). Limited information exists concerning the practices of health
departments in pursuit of preventive therapy for these groups because, to date, no
systematic studies have been conducted on the subject.
Applicants already in the United States must be screened and found free of infec-
tious TB before they can adjust their immigration status. Screening must be
performed by physicians designated as “civil surgeons” by the U.S. Department of
Justice/Immigration and Naturalization Service (INS). The procedure consists of an
initial tuberculin skin test. If the reaction size is ≥5 mm, a chest radiograph is required.
Persons whose results are compatible with TB must be referred to a health depart-
ment for treatment. Referral for possible preventive therapy also is recommended for
persons with skin-test reactions of ≥10 mm.
In contrast to the overseas program, less data are available regarding the yield of
the U.S. screening program. One program in Denver — where the health department
physician was the INS-appointed civil surgeon performing TB examinations —
detected an active TB rate of 40/100,000, which was similar to the rate in the country
of origin for most of those tested. The study also identified several candidates for
preventive therapy for whom the completion rate was higher than for candidates iden-
tified by other means (10 ).
The number of foreign-born persons who are screened and treated for TB infection
through mechanisms other than formal immigration processes is not known. Contact
tracing, an important component of the U.S. strategy for TB control, is a possible case-
finding mechanism. However, limited information is available on the usefulness of
this approach in identifying either persons suspected of having TB or persons who are
at high risk for preventive therapy among the foreign born. A study in Seattle docu-
mented that the yield for both the number of contacts and the number of
tuberculin-skin-test–positive contacts was higher among the foreign born than among
the U.S. born in the area, but the study population was too small to assess the useful-
ness of contact tracing as a case-finding tool among the foreign born (9 ).
TB-control programs have tried to identify foreign-born preventive-therapy candi-
dates through several other means, including screening migrant farm laborers, school
entrants, and participants in English-as-a-second–language (ESL) programs. However,
few of these efforts have been evaluated to assess the potential yield.
Efforts to provide screening and preventive therapy for the foreign born are limited.
Averting future cases of TB requires linking screening programs to prevention serv-
ices. However, few resources are available to health departments for large-scale
prevention efforts for foreign-born persons. Also, persons who do not consider them-
selves ill and who are from countries where TB is regarded as a stigma might be
reluctant to begin or complete preventive therapy (11 ).
TB-control programs in the United States also must strive to overcome perceptions
about tuberculin-skin–test results among persons who have been vaccinated pre-
viously against TB. Many countries vaccinate infants with BCG (live attenuated
vaccine) as part of their TB-control programs. For those persons, tuberculin sensitivity
is highly variable and depends on the strain of BCG used, the population vaccinated,
and the recency of vaccination because reactivity wanes over time (12 ). Moreover, no
reliable method exists to distinguish tuberculin reactions caused by BCG from those
caused by natural infections. Thus, some U.S. health-care providers are reluctant to
Vol. 47 / No. RR-16 MMWR 7
perform tuberculin skin tests on foreign-born patients with previous BCG vaccinations
because they think that substantial reactions are likely to be falsely positive.
Screening programs also are hindered by the unknown role of environmental my-
cobacteria in other parts of the world in producing false-positive reactions and by the
cultural barriers to providing services to persons who do not consider themselves ill
and who are from countries where TB is regarded as a stigma. Finally, the high levels
of isoniazid (INH) resistance in many countries of origin raise questions about the use-
fulness of INH preventive therapy among foreign-born populations.
TB Diagnosis
Data regarding the timeliness of TB diagnosis after the onset of symptoms are not
routinely collected for either U.S.- or foreign-born populations. Compared with U.S.-
born patients, a higher percentage of foreign-born patients have extrapulmonary TB
only. Among foreign-born patients with pulmonary TB, the percentage diagnosed on
clinical criteria alone is higher than among U.S.-born patients (14% versus 10%) (13 ).
Drug Resistance
Drug-resistance rates are higher among foreign-born populations than among the
U.S. born. In a recent study of drug resistance based on national TB surveillance data
for 1993–1996, levels of INH resistance were higher among TB patients born in Viet-
nam (18.3%), the Philippines (14.7%), and Mexico (9.8%) than among U.S.-born TB
patients (6.4%) (14 ). Levels of resistance to INH and rifampin for the three groups
were 2.1%, 2.1%, and 1.9%, respectively, which is similar to the rate of 2.0% for those
born in the United States. Among foreign-born TB patients from the three countries,
resistance levels were higher in new arrivals than in long-term residents.
TB Treatment Outcomes
The outcome of TB treatment is slightly better for foreign-born patients than for
U.S.-born patients (15 ). Among the foreign-born community, levels of completion
vary by country of origin, but among all the major immigrant groups, completion rates
equal or exceed those of TB cases among U.S.-born patients.
TB-HIV Coinfection
In the United States, HIV has not played a major role in TB cases among foreign-
born persons in most areas. The only exception is persons from Haiti. Recent studies
conducted in southern Florida indicated that half of the Haitians infected with TB
among those aged 25–44 years were also HIV positive (16 ). The low incidence of HIV
among foreign-born persons with TB might be partly attributable to the U.S. law pro-
hibiting persons with HIV infection from applying for overseas immigration (17 ). Also,
injecting-drug use has not emerged as a major problem among the foreign-born
population. However, areas (e.g., San Diego) that are experiencing increasing drug
use among the foreign born have noted a corresponding increase in HIV prevalence
among foreign-born TB patients in recent years (personal communication, Kathleen
Moser, M.D., M.P.H., San Diego Department of Health, May 1997).
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OVERVIEW OF THE WORKING GROUPS REPORT
Given the issues outlined previously, the Working Group on Tuberculosis Among
the Foreign Born was responsible for a) delineating the most important policy and
programmatic needs related to TB among foreign-born persons and b) providing rec-
ommendations for action by CDC and other federal agencies, health departments,
community-based organizations (CBOs), and private health-care providers to enhance
control efforts. The group’s deliberations centered on five topics —
• epidemiologic profiles of TB cases among foreign-born persons;
• case finding, screening, and preventive therapy;
• diagnosis and management;
• collaborations with CBOs; and
• training needs.
The remainder of this report is organized around these topics, with discussion of
key issues related to each, followed by the recommendations of the Working Group.
DEVELOPING EPIDEMIOLOGIC PROFILES OF TB CASES
AMONG FOREIGN-BORN PERSONS
Issues
Because the characteristics of foreign-born populations and TB cases among the
foreign born differ among public health jurisdictions in the United States, TB-control
efforts must be tailored to meet local needs. These efforts require developing detailed
epidemiologic profiles of TB cases among the foreign born. TB-control program staff
need to know the characteristics and outcomes of foreign-born patients with TB in
their jurisdictions. They also need information on sources of medical care in commu-
nities of the foreign born, care-seeking behaviors, delays in seeking care, community
organizations or structures with access to specific foreign-born populations, sources
of interpreter services, and sources of culturally appropriate health information.
Recommendations for Developing Epidemiologic Profiles of
TB Cases Among Foreign-Born Persons
CDC
• CDC should continue to expand data presented regarding TB cases among
foreign-born persons in annual surveillance reports (e.g., time person has been
in the United States when TB is diagnosed).
• CDC should develop guidelines to monitor disease prevalence in each reporting
jurisdiction to document the burden of disease represented by persons entering
the United States. Current TB case counts exclude foreign-born persons who re-
ceived TB treatment before entering the United States, even if these persons
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have documented disease and require months to years of treatment after entry.
Prevalence is an important measurement for assessing TB program needs given
the prolonged treatment courses required for each active case. These data
should be added to CDC’s annual surveillance reports.
• CDC should collaborate with international and national agencies and organiza-
tions, (e.g., the North American Chapter of the International Union Against TB
and Other Lung Diseases) as well as state and local health departments to de-
velop profiles of immigration trends and patterns at the global, national, state,
and local levels.
• CDC should help health departments use TB surveillance data to develop profiles
of TB cases among foreign-born persons in their jurisdictions (Appendix A). CDC
should develop prototype documents and the computer programs needed to
generate routine reports at state and local levels. CDC also can help identify and
direct health departments to other data sources, such as a) CDC’s Division of
Quarantine database on immigrants with Class B tuberculosis and b) INS and
U.S. Bureau of Census documents and data sets that might be useful for certain
rate calculations. (Note: Detailed calculations at the state and local levels will not
always be feasible.) 
• CDC should conduct and support studies to evaluate TB transmission, contact
tracing, and source investigations among foreign-born populations. Possible re-
search topics include a) the effects and yield of contact tracing with regard to
case prevention and completion of preventive therapy; b) TB transmission by
foreign-born patients to children; c) identification of groups at high risk for whom
to target screening; and d) strategies to address border issues.
Health Departments and TB-Control Programs
• Heath departments should develop baseline profiles of TB cases among foreign-
born persons in their jurisdictions (Appendix A). The frequency of subsequent
profiles and their use at the city or county level will be governed by the number
and percentage of cases among the foreign born. Annual profiles will be useful
management tools for states with a high incidence of TB among persons born in
other countries.
• Although much of the information needed to generate the epidemiologic profiles
already is collected as part of the “Reports of Verified Cases of Tuberculosis”
(RVCT), health departments in areas with large foreign-born populations should
consider including additional variables (e.g., whether persons were identified as
Class B1 or B2 cases on overseas screening). Information on case designations
(Class A, B1, B2, or B3) can also be used to measure the impact of overseas TB
screening on U.S. morbidity.
• As necessary, health departments should conduct special studies to complete
their epidemiologic profiles. Research could focus on a) determining who is pro-
viding health-care services to the foreign born; b) identifying factors that are
responsible for delays in TB diagnosis; c) identifying obstacles to care seeking;
d) assessing the role of managed-care organizations in the care of foreign-born
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TB patients; and e) determining the capability of local practitioners to provide
services for foreign-born populations.
• Health departments should work with CDC and other agencies to develop pro-
files of immigration trends and patterns at the global, national, and state and
local levels.
CASE FINDING, SCREENING, AND PREVENTIVE THERAPY
Case Finding and Contact Tracing
Issues
Active case finding can help identify cases of TB among foreign-born persons
whose access to health-care services might be more limited than that of persons born
in the United States. However, the yield of such case-finding efforts is influenced by
the following factors:
• Screening procedures before entry into the United States.
• Country or region of origin — Immigrants from the Philippines, Vietnam, Haiti,
Korea, and sub-Saharan Africa have higher rates of reported TB than immigrants
from other countries (6 ).
• Length of time in the United States — Regardless of country of origin, immi-
grants who have been in the United States for <5 years have higher rates of TB
than immigrants who have been in the United States >5 years (6 ).
• Current age and age at the time of U.S. entry — Older immigrants have higher
rates of TB disease than immigrants who are younger. Those who enter the
United States at an older age have higher rates than their counterparts who enter
at younger ages (6 ).
Other factors, (e.g., return travel to the country of origin, HIV status, living condi-
tions, and family constellation) also can affect contact tracing. All of these factors need
to be considered in deciding which groups, if any, should be the target of active case-
finding efforts.
Contact tracing is one form of active case finding and is an important component of
TB-control efforts in the United States, regardless of a patient’s country of origin. Al-
though the intent and methods of contact tracing for foreign-born persons do not
differ substantially from those for persons born in the United States, contact investi-
gations among foreign-born persons might have different dynamics. For example,
determining if transmission has occurred among “close” household contacts can be
difficult because of the high background prevalence of positive tuberculin reactions.
Expanding the contact investigation to those other than close household contacts re-
quires additional time, effort, and resources.
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Recommendations for Case Finding and Contact Tracing
CDC
• CDC should provide health departments with timely information on Class B en-
trants who need evaluation. CDC should help health departments set up
monitoring systems to ensure that evaluations of these entrants are completed.
• CDC should provide guidance and data to help health departments determine
priorities for active case finding beyond Class B1 and B2 immigrants.
• CDC should conduct and support studies and assessments of innovative meth-
ods of case finding.
• CDC should develop and disseminate measurement instruments and other tools
to help programs measure effectiveness and prevention effectiveness.
• CDC should develop interstate communication and notification methods for
tracking TB patients who might be highly mobile and easily lost to follow-up
(e.g., asking immigrants at the time of entry about plans for relocating).
Health Departments and TB-Control Programs
• Where appropriate, health departments should develop local plans for control-
ling TB among the foreign born through case finding, screening, and preventive
therapy. Emphasis should be on the community planning role of the health de-
partment and the implementation role of other providers in the community. The
plan should be specific to the characteristics of TB among the jurisdiction’s
foreign-born population and should include
– risk assessments of TB among the foreign born, based on local demographic
and epidemiologic profiles;
– data regarding expected patterns of immigration, based on information pro-
vided by INS;
– information provided by the local public health and TB-control programs about
their structure and resources;
– a list of community health centers and CBOs providing health-care and other
services to immigrant populations provided by local community outreach or-
ganizations; and
– recommendations on case finding, contact tracing, screening, and preventive
therapy based on recommendations of CDC and others.
• Health departments should conduct active case finding according to the follow-
ing three priorities:
Priority 1 — Immigrants with Class A TB. Health departments should ensure that
these patients are located, evaluated, and treated appropriately.
Priority 2 — Immigrants with Class B1 or B2 TB. Currently, no federal regulations
exist that prescribe follow-up procedures for those who have suspicious chest
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radiographs but negative sputum smears, although those persons are reported
to state health departments by federal authorities. The number who are actually
evaluated nationally is unknown, but in health departments where assessments
have been made, the percentage has been reported to range from 63% to ap-
proximately 95% (8 ). Each state and local TB-control program should therefore
have an active process to ensure that all Class B1 and B2 immigrants are located,
evaluated, and treated appropriately. Programs should develop a notification
process (e.g., timely transfer of Class B1 and B2 forms to the health department
with a prescribed “window” for action).
Priority 3 — Other Groups at High Risk. The next priority should be older immi-
grants (especially those aged >55 years), immigrants from countries with high
rates of TB, immigrants from high-risk areas who have been in the United States
<5 years, and/or other groups that are “producing” cases, as documented in the
epidemiologic profile.
• Health departments should determine other processes for case finding among
lower-risk foreign-born persons. These will likely center on sources of care for the
foreign born and will require fostering partnerships with those who provide such
care, including CBOs, community clinics, community health-care providers, and
foreign-trained physicians. The health department should involve these partners
in developing and implementing the proposed plan to combat TB in their com-
munity. The health department’s role should be to provide education, training,
and consultation.
• Health departments should ensure that the evaluation of Class B1 and B2 immi-
grants includes a thorough history, medical examination, and in many cases, a
repeat chest radiograph. Evaluation of lower-risk groups might include a) a
symptom check followed by a chest radiograph for persons with symptoms in-
dicative of TB; b) a purified protein derivative (PPD) tuberculin test followed by a
chest radiograph for PPD-positive persons; or c) screening with a chest radio-
graph without symptom history or PPD testing, based on whether screening is to
be used for both case finding and preventive therapy or for case finding only
(e.g., elderly foreign-born persons). The most effective strategy will depend on
the risk for disease among the population screened. Health departments should
include these strategies in their TB-control plans.
• Health departments should evaluate their case-finding strategies and determine
the operational outcomes and cost-effectiveness of different approaches. For ex-
ample, depending on the prevalence of TB disease among the population being
screened, symptom check and chest radiograph screening might be more cost-
effective than performing PPD screening with chest radiographs for persons with
positive PPD results.
• Contact tracing should continue according to CDC guidelines. Health depart-
ments should systematically collect data regarding the outcomes of contact
tracing among foreign-born populations and evaluate the yield and effective-
ness.
Vol. 47 / No. RR-16 MMWR 13
• Health departments should use CDC-developed interstate communication and
notification methods for tracking TB patients. Health departments should de-
velop intrastate tracking methods.
• Health departments should share information on lessons learned. TB incidence
among foreign-born persons is a fluctuating situation in many parts of the coun-
try. Communities that currently have few TB cases among the foreign born might
have more in the future. To transfer lessons learned, programs with large num-
bers of recent immigrants should systematically record their experiences with
case finding, contact tracing, screening, preventive therapy, and directly ob-
served preventive therapy (DOPT) and should document successful strategies.
Regional associations could make this topic a formal forum at periodic meetings.
Providers
• Community practitioners and physicians providing health services to foreign-
born persons from high-risk areas should have a high degree of suspicion for
anyone who is symptomatic and refer them, when possible, to a state TB-control
clinic.
Screening and Preventive Therapy
Issues
A substantial number of foreign-born persons are from countries where the preva-
lence of TB is many times higher than that reported for the United States. CDC
estimates that at least 7 million foreign-born persons in the United States are infected
with TB and that 140,000–210,000 (2%–3%) will develop disease after immigration un-
less they complete a regimen of preventive treatment.
Screening and providing preventive therapy to foreign-born persons are hindered
by the large number of persons to be screened, difficulties in diagnosis, difficulties in
gaining access to persons who should be screened, cultural and linguistic barriers,
and the perceived difficulty in interpreting tuberculin skin tests among persons who
have received BCG vaccine. In health departments already serving large numbers of
TB patients, efforts to initiate large-scale screening programs to identify additional
foreign-born persons with TB infection might be impeded by insufficient resources to
ensure completion of preventive therapy.
As of the publication of this report, data are scarce regarding the rate of completion
of preventive therapy among foreign-born persons with TB infection. Lack of data
thwarts efforts to evaluate the cost-effectiveness of screening and prevention pro-
grams or to measure or predict the impact of DOPT on completion rates, the impact of
directly observed therapy (DOT) for index cases on the preventive therapy completion
rates of their contacts, or the impact of more extensive screening programs.
Data are also lacking on the contribution of civil surgeons in identifying candidates
for preventive therapy, providing preventive therapy to foreign-born patients, and re-
ferring patients to local health departments for evaluation. Some physicians do not
place tuberculin-reactive foreign-born patients on preventive therapy because the
physicians attribute positive skin-test results to prior BCG vaccination. Some foreign-
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born candidates might not be started on preventive therapy because physicians find
difficulty in convincing patients of the value of this health intervention (18 ). Physi-
cians and patients have concerns about potential adverse effects or toxicity associated
with preventive therapy.
Recommendations for Screening and Preventive Therapy
CDC
Screening —
• CDC should develop guidelines to help state and local health departments de-
velop area-specific, cost-effective strategies for TB screening targeted to
foreign-born populations at high risk and ensure that resources are targeted to
areas of greatest need.
• CDC should develop guidelines for evaluating screening programs to assess
cost-effectiveness.
• CDC should provide information on any national policies related to TB screen-
ing, diagnosis, treatment, and preventive therapy in high-prevalence countries
that are the source of large numbers of reported U.S. cases (e.g., Mexico, the
Philippines, Vietnam, India, China, Haiti, and South Korea). CDC should make
this information available to appropriate health departments, universities,
hospitals, clinics, and private physicians to facilitate and maximize treatment
efforts.
• CDC should collect and disseminate data regarding drug-resistance preva-
lence and incidence by country. Data could be based on WHO surveys and on
information generated by U.S. states on immigrants with TB.
• CDC should conduct and support studies of screening practices in schools,
universities, ESL programs, CBOs, and managed-care organizations. The stud-
ies should document screening and preventive therapy practices, the impact
of the screening practices on case finding and disease prevention, and cost-
effectiveness.
• Certain approaches might be better than others at screening undocumented
persons. CDC should ensure that screening strategies identify the most effec-
tive approaches without excluding or discouraging undocumented
populations from seeking TB evaluation and follow-up.
• Community screening plans should address the differing opinions of provid-
ers regarding interpretations of positive tuberculin tests. CDC or the American
Thoracic Society (ATS) should consider developing a decision algorithm to
help providers assess the importance of BCG vaccination history among dif-
ferent immigration groups and age cohorts.
Completion of Preventive Therapy —
• CDC should encourage and assist health departments in developing ongoing
systems for compiling and analyzing data regarding the completion of preven-
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tive therapy among foreign-born persons. CDC also should assist health de-
partments in analyzing the data regarding cost-effectiveness of efforts to
improve completion of preventive therapy among the foreign born.
• CDC should conduct and support cost-effectiveness analyses of preventive
therapy program activities to establish criteria for program evaluation.
• CDC should conduct and support studies to evaluate the referral process be-
tween civil surgeons and health departments for immigration status
adjustment applicants who are TB-infected and need evaluation for preventive
therapy.
• CDC should conduct and support clinical and operational research studies to
identify and replicate strategies to increase adherence to preventive therapy
among target populations.
• CDC should conduct and support studies on the effectiveness of INH preven-
tive therapy among populations with high background levels of INH resistance
and the possible role of alternative treatments (e.g., rifampin).
• CDC should conduct and support studies on TB cases prevented as a result of
various preventive therapy strategies.
• CDC should work with federal, state, and local agencies that award Medicaid
managed-care, primary care, and other direct-service delivery funds to ensure
that the assessment of TB prevention indicators are built into funding mecha-
nisms.
• CDC should collect samples of available educational materials and consider
dissemination mechanisms (e.g., a TB Internet website). These materials
should cover diagnosis of TB infection, the TB skin test, BCG vaccinations, and
the importance of preventive therapy. Materials should be posted in a full-text
English version, with a list of available translations and sources.
Health Departments and TB-Control Programs
Screening —
• Health departments should establish screening goals and priorities. Because
the number of foreign-born persons who are eligible for screening could be
large, TB programs should use their epidemiologic profiles to prioritize and
target screening to groups who are at the highest risk for TB infection, who are
accessible for screening, and who are likely to complete preventive therapy.
Each community’s plan to combat TB among foreign-born persons should pro-
vide recommendations for groups identified as screening priorities as well as
recommendations for lower-risk groups. The role of CBOs, clinics, and other
providers also should be specified, with recommendations for targeted pro-
grams for health departments.
Persons at highest risk for infection can be identified by examining
epidemiologic trends in TB disease in the community, results of previous or
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existing screening programs, and immigration trends. Data regarding accessi-
bility for screening and likelihood of success with adherence-enhancing efforts
(e.g., DOPT) might not be readily available. Data-gathering strategies might
include discussions with CBO staff and providers, reviews of the medical lit-
erature, reviews of program data, and information exchange with other
programs.
Based on this information, possible candidates for screening include a) school
entrants, b) ESL students, c) migrant and seasonal farm workers, and d) per-
sons in occupations with large numbers of foreign-born persons (e.g., food
handlers, hotel staff, and poultry industry workers). Screening might be con-
ducted at schools, job sites, health departments, private providers’ offices, or
community clinics. Comprehensive screening strategies (e.g., screening of all
new school entrants in areas with substantial foreign-born populations) have
the advantage of not stigmatizing the foreign born. Any screening program
must include plans and resources for evaluating candidates for preventive
therapy and for ensuring completion of therapy, if needed.
• Health department staff should communicate with civil surgeons and private
providers to facilitate the evaluation and preventive treatment of TB-infected
applicants for immigration adjustment. Health departments can help civil sur-
geons by becoming familiar with Technical Instructions for Medical
Examination of Aliens in the United States, the manual used by civil surgeons,
and by serving as a technical resource. Health departments need to consider
whether they have the resources to provide preventive therapy to TB-infected
adjustment applicants before initiating such an activity.
• Health departments should evaluate their screening programs at least annu-
ally to assess progress toward goals.
Completion of Preventive Therapy —
• Health departments should ensure that plans for screening include identifying
adequate resources and a process to ensure the completion of preventive
therapy. If sufficient resources do not exist to ensure completion of preventive
therapy, plans for screening should be reconsidered. In some instances, DOPT
might be an effective strategy. However, issues of resource allocation and ac-
ceptance can limit its application.
• Health departments should evaluate preventive therapy programs to deter-
mine their effectiveness and impact. Programs should establish goals for the
percentage of persons screened who have their skin tests read, the percentage
referred for evaluation who are actually evaluated, the percentage recom-
mended for preventive therapy who actually begin therapy, and the
percentage beginning therapy who complete that therapy. Although formal
cost-effectiveness analyses are not necessary or feasible for most health de-
partments, the cost of the program, including the cost per participant
completing preventive therapy, should be part of any evaluation.
Vol. 47 / No. RR-16 MMWR 17
• Health departments should determine the magnitude and scope of nonadher-
ence to preventive therapy among the foreign-born populations in their
jurisdictions.
• Health departments should ensure that culturally sensitive and language-
appropriate educational materials on TB infection, BCG vaccinations, skin test-
ing, and the importance of preventive therapy are available to foreign-born
persons at high risk for disease.
• Health departments should collaborate with  practitioners to develop and
monitor preventive therapy practices.
• Health departments should undertake pilot approaches for improving comple-
tion rates for preventive therapy among less adherent high-risk groups.
DIAGNOSING AND MANAGING TB
Recognizing TB
Issues
In their pursuit of health care in the United States, foreign-born persons encounter
many barriers that can impede the recognition of TB (e.g., language and cultural dif-
ferences, which hinder communication between foreign-born patients and health-care
providers). Moreover, many foreign-born patients are unaware of how to gain access
to the health-care system. Even when they access health care, they often are ineligible
for employee-based health insurance or Medicaid and cannot afford to purchase pri-
vate insurance.
Attitudes and behaviors can pose other impediments to the recognition of disease
among the foreign born. Because of the social stigma of TB or cultural beliefs about
disease causation, progression, and treatment, some foreign-born persons might
deny the presence of symptoms or known disease. They might delay seeking care
even when illness is recognized because of other priorities in their lives (e.g., securing
food and shelter, job responsibilities, and family concerns). Undocumented persons
(e.g., illegal border crossers and visa “over-stayers”) might delay diagnosis and treat-
ment because of fear of detection and possible deportation. Delays can result in
diagnosis of disease at more advanced stages, which translates into the possible need
for hospitalization and more expensive care, as well as prolonged periods of infec-
tiousness and a greater likelihood of disease transmission. Medical providers and
laboratories also can impede or delay disease recognition. Foreign-born patients
might seek care from medical providers who are not fully aware of, or up-to–date on,
the latest CDC and ATS guidelines for TB diagnosis and treatment.
Persons of foreign origin who enter the country on nonimmigrant visas create spe-
cific problems. Unlike immigrants and refugees, nonimmigrant business persons,
students, and dependents are not required to be medically evaluated for TB before
entering the country. If they later want to adjust their immigration status to that of
legal permanent resident while remaining in the United States, they are required to be
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screened by a civil surgeon designated by INS. Civil surgeons have valid U.S. medical
licenses but have no other TB-related educational or training requirements and re-
ceive no postdesignation monitoring or required continuing education. In most areas
of the country, a lack of coordination and communication exists between civil sur-
geons and state and local health departments.
Recommendations for Recognizing TB
CDC
• Via direct links to INS, CDC should initiate efforts to determine the number of
adjustment-of-status examinations conducted in various jurisdictions and the
names of civil surgeons by jurisdiction. CDC should encourage INS to require
training, certification, and mandatory continuing education for civil surgeons.
• CDC should develop training materials for civil surgeons to improve their ability
to screen immigrants for TB infection and disease and to make the appropriate
referrals for follow-up. The materials could be designed as self-study tools or as
course curricula for continuing education classes provided by health depart-
ments.
• CDC should conduct and support studies to identify barriers to TB diagnosis and
care among foreign-born populations. Helpful information could be provided
through operational and behavioral research related to access to care; knowl-
edge and beliefs of patients, community providers, and physicians; and other
factors related to recognition of disease among foreign-born populations. CDC
also should consider lessons learned from medical anthropology research on
other diseases that might be relevant to TB.
Health Departments and TB-Control Programs
• Health departments should devise, identify, and implement early disease recog-
nition strategies that are focused on specific foreign-born populations at high
risk. Successful strategies should be promoted as models for other regions.
• Health departments should develop ongoing educational seminars on TB diag-
nosis for private physicians, especially civil surgeons and physicians in the
community who treat foreign-born persons.
• Health departments should be encouraged to make contact with local civil sur-
geons to offer training and encourage collaboration and referrals.
• Health-care providers and health departments should not be required to question
foreign-born patients to determine if they are legal residents under federal immi-
gration law.
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Completing Treatment
Issues
Problems related to completion of treatment center on nonadherence, inadequate
tracking systems, information gaps, and drug resistance. Nonadherence to treatment
is a major problem in TB-control programs worldwide. Adherence is impeded by the
same cultural and economic barriers that hinder timely diagnosis of disease among
foreign-born persons.
Tracking and communication networks also are inadequate. Some foreign-born
persons (e.g., migrant and seasonal farm workers) are very mobile and move among
countries and states and across the U.S.-Mexico border while under treatment. Com-
pletion of treatment in these cases is impeded by the lack of efficient tracking and
referral systems. Similarly, foreign-born patients sometimes return to their country of
origin before completion of treatment, with no follow-up of care. Essentially no com-
munication exists between TB controllers in the United States and their counterparts
in foreign countries, with the exception of the U.S.-Mexico border region where lines
of communication are being established.
TB treatment is also hindered by gaps in information. U.S. health-care providers
have little information on current medical guidelines for TB treatment and diagnosis
in the developing world. Even U.S. TB controllers are not knowledgeable about the
screening procedures and treatment regimens used in the countries of origin for many
of their foreign-born patients. In addition, scant program data are available on the
common barriers to adherence affecting foreign-born subpopulations in the United
States and even less on the unique problems related to adherence among specific
groups within foreign-born subpopulations. Although data regarding completion of
treatment are collected via the national RVCT system, the data have not been analyzed
by subpopulation or region to help define the scope and magnitude of adherence is-
sues among the foreign born.
Foreign-born patients who were treated in their home countries pose special prob-
lems. U.S. physicians who treat foreign-born persons with TB are rarely able to obtain
medical records from countries where the patients were treated previously. If the re-
cords are available, the medical information is likely to be in an unfamiliar language or
format. National TB-control program reports from countries that are sources of large
numbers of TB cases among the foreign born often lack reliable data regarding rates
of relapse, drug resistance, and completion of therapy.
Finally, because resources and infrastructure for TB-control programs are severely
limited in many foreign countries, persons treated for TB in these countries might
receive inadequate or incomplete treatment. This puts foreign-born persons at greater
risk for disease recurrence with drug-resistant strains, which complicates and length-
ens the course of treatment. Some persons with multiple resistant strains are
chronically ill and persistently infectious. Although the total number of these patients
with treatment-resistant TB is small, the cost associated with their medical care is
many times that of patients with drug-susceptible disease. Treating these patients can
severely strain local health department resources, especially because foreign-born
populations are disproportionately underinsured or uninsured.
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Recommendations for Completing Treatment
CDC
• CDC should encourage and help state and local health departments conduct pe-
riodic analyses of the data regarding reported TB cases among the foreign born
to determine the magnitude and scope of nonadherence to treatment.
• CDC should support regional TB associations in facilitating collaborations with
immigrants’ countries of origin.
• In conjunction with INS, CDC and the model TB centers* should develop and
distribute materials in various languages for applicants for immigration adjust-
ment. The materials developed should explain the TB-screening requirements
for legal permanent residency.
• CDC, in conjunction with WHO, should compile drug-resistance/drug-
susceptibility data from the appropriate countries as available and disseminate
the data to jurisdictions with large numbers of foreign-born TB patients.
Health Departments and TB-Control Programs
• Health departments should identify the characteristics of the foreign-born pa-
tients in their jurisdictions who are most likely to be nonadherent. They should
develop approaches to address the barriers that cause these patients to drop out
before completion of treatment. In areas with diverse populations of foreign-
born persons, studies should be undertaken to determine problems related to
adherence by ethnic subgroup.
• Whenever possible, health departments should hire outreach workers and case
managers from the same cultural, ethnic, and linguistic background as the pa-
tient populations they serve. Outreach staff can familiarize patients with the local
health-care system, ensure that patients receive the necessary examinations, fa-
cilitate DOT, and conduct intermittent home visits for pill counts and client
interviews to help identify adherence-related problems.
• Health departments should periodically evaluate their educational materials on
TB for foreign-born patients to ensure that the materials are accurate, up-to–date,
in agreement with the most current CDC and ATS statements, and appropriate to
the needs and characteristics of their more recent immigrants.
• Health departments should maximize their collaboration with refugee health pro-
grams to help their patients complete treatment.
• Communication between TB controllers in the United States and Mexico should
be continued and expanded to facilitate continuity of medical care for TB patients
who frequently move back and forth across the border.
*CDC funds three model TB centers — San Francisco’s Francis J. Curry National TB Center;
New York City’s Charles P. Felton National TB Center at Harlem Hospital; and Newark’s New
Jersey Medical School National TB Center. These model centers provide comprehensive and
coordinated state-of-the–art diagnostic, treatment, prevention, and patient education services
for those persons infected with TB, those suspected of being infected, their contacts, and other
persons at risk for TB. 
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• Health departments in jurisdictions with large numbers of foreign-born TB pa-
tients should become familiar with the treatment policies and regimens of the
major countries of origin. They also should ascertain BCG-vaccination policies
and practices in those countries.
COLLABORATING WITH CBOs
Issues
CBOs and health departments can be strong partners in efforts to prevent and con-
trol TB among foreign-born persons who are at high risk for the disease. However, in
many communities, health departments and relevant CBOs have little or no contact
and thus lose opportunities to maximize their effectiveness. Also, many health-service
CBOs have limited understanding of TB-related issues and often are unable or unwill-
ing to provide screening and preventive therapy.
Recommendations for Collaborating with CBOs
Health Departments and TB-Control Programs
• Health departments should conduct an inventory of community organizations
and resources in their jurisdictions to determine which CBOs, community lead-
ers, associations, and coalitions can be resources in the TB-control effort. The list
should differentiate between health-service CBOs and those that cannot or do
not provide health services. Useful sources of information might include a) TB
outreach workers, b) members of foreign-born communities at risk for TB, and
c) directories or listings of health department and CBO services. If no such direc-
tories are available, health department staff could work with one or two CBOs to
compile such a resource for the community.
• Health departments should identify the most influential organizations for per-
sons who are foreign born among those listed in any directory of resources. At a
minimum, these organizations should have substantial interactions with persons
at high risk for TB, be effective at working in the community, and be willing to
work with the health department. Recognizing which CBOs might contribute as
partners in community TB prevention and control efforts targeted to the foreign
born is important. Examples include religious organizations, community action
agencies, community coalitions, vocational assistance or job programs, recog-
nized community leaders, professional associations, block organizations, health
centers, student organizations, and informal community groups.
• Health departments should develop partnerships with influential organizations
and leaders and share resources to serve communities at risk for TB. Health de-
partment staff can
– serve as sources of information about health-related issues;
– help with medical referrals;
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– provide TB-related screening, prevention, and other medical care services;
– provide TB-related services in CBOs or other facilities; and
– work with CBOs to help newly arrived immigrants and refugees obtain appro-
priate TB-related education, screening, and follow-up.
• Health departments should invite representatives of key CBOs to serve on state
and local TB advisory committees and coalitions. CBO representation is essential
to ensure “buy-in” and to gain community expertise in developing workable TB
prevention and control strategies.
• Health departments should work with health-service CBOs to develop more com-
plementary roles, more effective coordination of services, and better use of
existing resources. CBO roles should be consistent with each organization’s
stated and unstated interests, missions, goals, and objectives. Some appropriate
roles for CBOs might be to
– profile the characteristics, health beliefs, and other attributes of the commu-
nity’s foreign-born population(s);
– locate patients who previously have been lost to follow-up (if confidentiality
issues can be resolved);
– help provide TB-related health education to high-risk populations;
– provide outreach and screening services, with or without financial support
from the health department;
– serve as a site for DOT and/or preventive therapy in close collaboration with
health department staff (e.g., a health department might detail a staff person to
provide health education, screening, and preventive therapy at a CBO);
– identify and provide referral services;
– provide and/or distribute incentives and enablers to persons receiving treat-
ment or preventive therapy;
– enhance the credibility of health-education messages or outreach activities;
– translate health-education or training materials; and
– identify contacts abroad with whom to begin developing relationships.
• Health departments should initiate the development of prevention-outcome
measures for their communities.
TRAINING NEEDS
Issues
Some problems associated with TB among the foreign born stem from communi-
cation barriers, cultural and cognitive dissonance between providers and patients, and
gaps in provider training. Foreign-born patients might not know how to gain access to
the health-care system. Providing TB prevention and control services to foreign-born
persons might be impeded by linguistic, ethnic, cultural, socioeconomic, or other dif-
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ferences between patients and health workers. Foreign-born health-care providers
might be uninformed about the latest U.S. recommendations and practices related to
TB and, thus, be unable to provide optimal diagnostic services, preventive therapy,
and management to the foreign born.
TB-related training and educational efforts to support and strengthen TB-control
activities need to be linked closely to the overall TB-control strategies for the foreign
born. When foreign-born populations are identified and health-care providers for
these populations are defined, training efforts can be developed and implemented.
Education should be targeted to providers, patients, and community workers.
Recommendations for Training Needs
Health Departments and TB-Control Programs
• Health departments should undertake training needs assessments. These as-
sessments should include a determination of the practitioners’ knowledge, skills,
and attitudes regarding any planned TB-control interventions. Helpful reference
sources might include materials and recommendations from the San Francisco
Model Center training summit scheduled for October 1998.
• TB-related training and educational efforts focused on the foreign born should
reflect the educational, cultural, and ethnic background of the target audience
and should consider the unique characteristics of the trainees (e.g., foreign-born
health-care providers, other health-care providers who work with the foreign-
born, or foreign-born patients).
• Health departments should adapt educational materials for use by specific
foreign-born populations. Adaptations should consider language, concepts, level
of comprehension, and message delivery. Health departments also should evalu-
ate the message-delivery tools to assess the effectiveness of outreach efforts.
• In collaboration with CBOs, health departments should provide training to
health-care providers of foreign-born groups at risk for TB, with the goal of en-
hancing screening efforts, improving case management, and increasing
completion of preventive therapy. Possible topics include diagnosis of TB infec-
tion, the TB skin test, preventive treatment, BCG vaccination, case reporting, case
management, availability of TB resources, and partnership building. Programs
also should include training in the use of interpreters and education about cul-
tural beliefs and practices that can hinder case finding, treatment, and preventive
therapy (e.g., cultural concepts about TB, BCG-vaccination use, or barriers to ef-
fective communication with foreign-born populations). Ethnologic research (e.g.,
EthnoMed* data) might be helpful to trainers in gaining a better understanding
of their foreign-born constituents. To encourage interest in and attendance at
educational programs, health departments and CBOs should consider sponsor-
ing special luncheon or dinner meetings, offering academic credit, and
advertising to foreign-born medical associations.
*Sponsored by the University of Washington’s Harborview Medical Center in Seattle, EthnoMed
is a database containing medical and cultural information about refugee groups (Internet
website, <http://weber.u.washington.edu/-ethnomed>.)
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• Health departments should train CBO staff who might not have a health back-
ground but who can give PPDs and provide simple epidemiologic data. The
importance of this training should not be underestimated when planning collabo-
rative efforts with CBOs.
CONCLUSION
This report presents a plan for federal, state, and local TB-control programs to ad-
dress TB among the foreign-born population residing in the United States. Not all
TB-control programs will have the resources to implement all aspects of this plan, and
some TB-control programs will not have the same issues identified in this report.
However, these recommendations can provide assistance in identifying programmatic
gaps and in establishing priories for a TB-control and prevention plan that will yield
the greatest positive results for foreign-born persons.
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APPENDIX
SAMPLE EPIDEMIOLOGIC PROFILE
Data   Sources   How data will be used
Demographics
Patient’s age at diagnosis
Patient’s age at entry to United
 States
Country of origin
Sex
Employed (Y/N)
“Reports of Verified Cases of
Tuberculosis”
Targeting of programmatic
efforts
Years in United States at time of
diagnosis
“Reports of Verified Cases of
Tuberculosis”
Identification of at-risk
groups; identification of
missed opportunities for
prevention
Source case identified
 (especially in pediatric cases)
Add to “Reports of Verified
Cases of Tuberculosis”
Transmission in foreign-born
community; strategy for case
finding
Clinical/diagnostic
• Previous treatment for TB
  (Past preventive treatment?)
• Acid-fast bacilli smear
• Acid-fast bacilli culture
• Drug susceptibility
• HIV status
Add to “Reports of Verified
Cases of Tuberculosis”
Program management;
issues surrounding delays in
diagnosis; issues regarding
treatment; issues regarding
preventive therapy;
advocacy; program planning
Case Management
Type of provider “Reports of Verified Cases of
Tuberculosis”
Targeting provider education
Patient on directly observed
 therapy?
“Reports of Verified Cases of
Tuberculosis”
Patient management
Completion of therapy Add to “Reports of Verified
Cases of Tuberculosis”
Program management;
identifying high-risk patients;
targeting programs.
Drug regimen
Drug resistance
“Reports of Verified Cases of
Tuberculosis” and WHO
Program management
Case Finding
Screening program
• Number screened
• Number infected
• Cases found
• Preventive treatment
  completed
State and local health
departments
Evaluation of program
performance
The following table represents some elements of a tuberculosis (TB) profile for a
foreign-born person that should be considered for use in state and local health depart-
ments.
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Data   Sources   How data will be used
Contact tracing
• Done or not?
• Number of contacts
  identified per case
• Number of cases with no
  contacts identified
• Number (%) infected with 
  no disease
• Number (%) placed on
  preventive therapy
• Number (%) completed
  preventive therapy
• Cases found
CDC and state and local
health departments
Evaluation of program
performance
Class B1/B2 Cases
Number of notifications CDC/National Center for
Infectious
Diseases/Division of
Quarantine
Resource allocation
Number investigated CDC/National Center for
Infectious
Diseases/Division of
Quarantine and state and
local health departments
Resource allocation
Number eligible for prevention
Number with disease
Number started on treatment
Number completed treatment
CDC/National Center for
Infectious
Diseases/Division of
Quarantine and state and
local health departments
Prioritization of resources
Civil Surgeon Referral
Number with status readjusted U.S. Department of
Justice/Immigration and
Naturalization Service
Assessment of potential
burden to health
department
Number eligible for prevention
Number with disease
Number referred to health
 department (asylees)
U.S. Department of
Justice/Immigration and
Naturalization Service and
local health department
Resource allocation;
advocacy for medical
services
Qualitative Data on Screening
Special studies
• Schools/universities
• English-as-second–language
  schools
• Community-based
 organizations
Local health departments Program planning/resource
allocation; strategy for case
finding
Immigration Profile
Current population profiles
New immigration
• Overseas immigrants
• Adjustment of status
• Asylum seekers
U.S. Census Bureau and
U.S. Department of
Justice/Immigration and
Naturalization Service
Program planning;
resource allocation;
advocacy for medical
services
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Data   Sources   How data will be used
Special Studies
Barriers to accessing care
• Language
• Financial
• Legal
• Cultural
• Knowledge
• Health beliefs
State and local health
departments
Issues regarding access —
advocacy for medical
services
Patient versus provider delays
• Duration of symptoms
  before diagnosis
• Number of visits made
  before diagnosis
• Type of provider
State and local health
departments
Issues regarding early
diagnosis; patient and
provider education
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